Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,507,878
  • Shares Outstanding, K 60,436
  • Annual Sales, $ 198,320 K
  • Annual Income, $ -169,430 K
  • 60-Month Beta 0.68
  • Price/Sales 7.90
  • Price/Cash Flow N/A
  • Price/Book 6.27
Trade TVTX with:

Options Overview

Details
  • Implied Volatility 112.00%
  • Historical Volatility 45.99%
  • IV Percentile 79%
  • IV Rank 25.47%
  • IV High 271.19% on 01/29/21
  • IV Low 57.59% on 03/30/21
  • Put/Call Vol Ratio 0.05
  • Today's Volume 81
  • Volume Avg (30-Day) 67
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 3,387
  • Open Int (30-Day) 983

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.56
  • Number of Estimates 4
  • High Estimate -0.40
  • Low Estimate -0.68
  • Prior Year 0.02
  • Growth Rate Est. (year over year) -2,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.39 +11.43%
on 03/30/21
28.35 -11.99%
on 03/18/21
-2.70 (-9.76%)
since 03/16/21
3-Month
22.39 +11.43%
on 03/30/21
33.09 -24.60%
on 02/02/21
-2.77 (-9.99%)
since 01/15/21
52-Week
13.63 +83.05%
on 04/17/20
33.09 -24.60%
on 02/02/21
+11.49 (+85.36%)
since 04/16/20

Most Recent Stories

More News
NASDAQ Drops Another 2.7% as Bond Yields Rise Again

NASDAQ Drops Another 2.7% as Bond Yields Rise Again

SAIL : 49.83 (-0.82%)
MMSI : 61.78 (+0.68%)
RDUS : 19.71 (-0.15%)
TTD : 718.86 (-2.20%)
BJ : 45.20 (+1.12%)
NVAX : 227.35 (+12.50%)
PRIM : 34.90 (+0.35%)
CAR : 79.15 (+1.24%)
MNKD : 4.18 (-2.79%)
ZUMZ : 45.70 (-1.21%)
TVTX : 24.95 (-3.82%)
GH : 158.50 (-0.44%)
VXRT : 5.35 (-1.38%)
QDEL : 128.83 (+2.26%)
PLAN : 60.51 (-3.09%)
NFLX : 546.54 (-0.49%)
AAPL : 134.16 (-0.25%)
AMZN : 3,399.44 (+0.60%)
GOOG : 2,297.76 (+0.05%)
FB : 306.18 (-0.53%)
MSFT : 260.74 (+0.48%)
Travere Therapeutics (TVTX) Reports Q4 Loss, Lags Revenue Estimates

Travere (TVTX) delivered earnings and revenue surprises of -451.16% and -0.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

TVTX : 24.95 (-3.82%)
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?

During Novavax's (NVAX) upcoming fourth-quarter earnings call, investor focus will be on the company's progress with its COVID-19 vaccine candidate, NVX-CoV2373.

SNY : 51.30 (+1.20%)
NVAX : 227.35 (+12.50%)
XLRN : 122.05 (-1.60%)
TVTX : 24.95 (-3.82%)
What's in the Cards for BioNTech (BNTX) This Earnings Season?

On BioNTech's (BNTX) fourth-quarter earnings call, investors are likely to focus on sales number for its COVID-19 vaccine, BNT162b2, which has been developed in partnership with Pfizer.

PFE : 38.57 (+2.58%)
XLRN : 122.05 (-1.60%)
BNTX : 151.54 (+7.69%)
TVTX : 24.95 (-3.82%)
Travere Therapeutics (TVTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Travere (TVTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TVTX : 24.95 (-3.82%)
Interesting TVTX Put And Call Options For April 16th

Investors in Travere Therapeutics Inc saw new options become available this week, for the April 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TVTX options...

TVTX : 24.95 (-3.82%)
Inovio (INO) to Report Q4 Earnings: What's in the Cards?

On Inovio's (INO) fourth-quarter earnings call, investor focus will be on updates on the company's progress with the development of its COVID-19 vaccine candidate, INO-4800.

LXRX : 5.05 (-3.07%)
INO : 8.74 (-3.00%)
XLRN : 122.05 (-1.60%)
TVTX : 24.95 (-3.82%)
Stocks Still Near All-Time Highs Despite Sluggish Week

Stocks Still Near All-Time Highs Despite Sluggish Week

NUS : 52.99 (-0.11%)
BBIO : 55.12 (+0.31%)
MCFT : 27.36 (+0.26%)
MNKD : 4.18 (-2.79%)
TVTX : 24.95 (-3.82%)
AIMC : 62.95 (+0.30%)
FISV : 125.09 (-0.35%)
BTG : 5.11 (+2.61%)
AAWW : 66.87 (+1.77%)
Why Earnings Season Could Be Great for Travere Therapeutics (TVTX)

Travere Therapeutics (TVTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

TVTX : 24.95 (-3.82%)
Travere Therapeutics Reaches Analyst Target Price

In recent trading, shares of Travere Therapeutics Inc have crossed above the average analyst 12-month target price of $31.33, changing hands for $31.56/share. When a stock reaches the target an analyst...

TVTX : 24.95 (-3.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 28.22
2nd Resistance Point 27.34
1st Resistance Point 26.14
Last Price 24.95
1st Support Level 24.07
2nd Support Level 23.19
3rd Support Level 21.99

See More

52-Week High 33.09
Fibonacci 61.8% 25.66
Last Price 24.95
Fibonacci 50% 23.36
Fibonacci 38.2% 21.06
52-Week Low 13.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar